1-chloro-7-iodoheptane | CAS:99669-96-2

We serve 1-chloro-7-iodoheptane CAS:99669-96-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-chloro-7-iodoheptane

Chemical Name:1-chloro-7-iodoheptane
CAS.NO:99669-96-2
Synonyms:1-chloro-7-iodoheptane
Heptane, 1-chloro-7-iodo-
Molecular Formula:C7H14ClI
Molecular Weight:260.54400
 
Physical and Chemical Properties:
Density:1.494
Boiling point:95ºC
Index of Refraction:1.512
 
Specification:
Appearance:Pale yellow liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:The substance is unstable and should be kept away from light and refrigerated
Application:Organic synthesis intermediate



Contact us for information like 1-chloro-7-iodoheptane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Heptane, 1-chloro-7-iodo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Heptane, 1-chloro-7-iodo- Use and application,Heptane, 1-chloro-7-iodo- technical grade,usp/ep/jp grade.


Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.isophthalonitrile manufacturer This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.4-(Trifluoromethoxy)benzyl bromide supplier Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.2,7-Dibromo-9-(4-bromophenyl)-9H-carbazole vendor Take penicillin industrial salt and vitamin C as examples. They are the two strategic varieties of chemical raw materials in China, and they are also representatives of severe overcapacity.The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.